SMS Pharmaceuticals informs about disclosure
SMS Pharmaceuticals has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 30, 2025 for Potluri Infra Projects LLP.
The above information is a part of company’s filings submitted to BSE.
